All lobbying filings

DLA PIPER LLP (US)

Lobbying for IRA WATCHDOG · Coalition analyzing impact of Medicare Drug Price Negotiation on patients.

Filing Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 11, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

RACHEL PORTMAN New on this filing

Previously held: Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman
MARGARET MARTIN New on this filing

Previously held: Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Impact of Medicare Drug Price Negotiation Program on patients.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

ASTRAZENECA PLC

United Kingdom · Cambridge CB2 0AA · owns 0% of the client · contributed $0.00

Affiliated organizations 4

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

ASTRAZENECA PHARMACEUTICALS LP

Wilmington, Delaware
BRISTOL-MYERS SQUIBB COMPANY

Princeton, New Jersey
ELI LILLY AND COMPANY

Indianapolis, Indiana
MERCK & CO., INC.

Rahway, New Jersey

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.